These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38851437)

  • 41. Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy.
    Di Caro G; Cortese N; Castino GF; Grizzi F; Gavazzi F; Ridolfi C; Capretti G; Mineri R; Todoric J; Zerbi A; Allavena P; Mantovani A; Marchesi F
    Gut; 2016 Oct; 65(10):1710-20. PubMed ID: 26156960
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tertiary lymphoid structures in head and neck squamous cell carcinoma.
    Zhu J; Lu H; Wang K; Liu B; Yan J
    Transl Oncol; 2024 Jun; 44():101949. PubMed ID: 38583352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer.
    An Y; Sun JX; Xu MY; Xu JZ; Ma SY; Liu CQ; Liu Z; Wang SG; Xia QD
    Front Immunol; 2022; 13():1049884. PubMed ID: 36420257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors.
    Zhang WH; Wang WQ; Han X; Gao HL; Xu SS; Li S; Li TJ; Xu HX; Li H; Ye LY; Lin X; Wu CT; Long J; Yu XJ; Liu L
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33055204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma.
    Li H; Wang J; Liu H; Lan T; Xu L; Wang G; Yuan K; Wu H
    Aging (Albany NY); 2020 Feb; 12(4):3451-3472. PubMed ID: 32087064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor-Associated Tertiary Lymphoid Structures: A Cancer Biomarker and a Target for Next-generation Immunotherapy.
    Dieu-Nosjean MC
    Adv Exp Med Biol; 2021; 1329():51-68. PubMed ID: 34664233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Features and clinical significance of tertiary lymphoid structure in cutaneous squamous cell carcinoma.
    Wu YH; Wu F; Yan GR; Zeng QY; Jia N; Zheng Z; Fang S; Liu YQ; Zhang GL; Wang XL
    J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):2043-2050. PubMed ID: 35881141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of a risk score model based on tertiary lymphoid structure-related genes for predicting immunotherapy efficacy in non-small cell lung cancer.
    Mei SQ; Liu JQ; Huang ZJ; Luo WC; Peng YL; Chen ZH; Deng Y; Xu CR; Zhou Q
    Thorac Cancer; 2024 May; 15(14):1119-1131. PubMed ID: 38558529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immature central tumor tertiary lymphoid structures are associated with better prognosis in non-small cell lung cancer.
    Xiaoxu D; Min X; Chengcheng C
    BMC Pulm Med; 2024 Mar; 24(1):155. PubMed ID: 38532454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma.
    Li Q; Liu X; Wang D; Wang Y; Lu H; Wen S; Fang J; Cheng B; Wang Z
    Int J Oral Sci; 2020 Sep; 12(1):24. PubMed ID: 32934197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tertiary lymphoid structures accompanied by fibrillary matrix morphology impact anti-tumor immunity in basal cell carcinomas.
    Byers C; Gill M; Kurtansky NR; Alessi-Fox C; Harman M; Cordova M; Gonzalez S; Guitera P; Rotemberg V; Marghoob A; Chen CJ; Dy J; Kose K; Rajadhyaksha M; Sahu A
    Front Med (Lausanne); 2022; 9():981074. PubMed ID: 36388913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peritumor tertiary lymphoid structures are associated with infiltrating neutrophils and inferior prognosis in hepatocellular carcinoma.
    Zhang T; Lei X; Jia W; Li J; Nie Y; Mao Z; Wang Y; Tao K; Song W
    Cancer Med; 2023 Feb; 12(3):3068-3078. PubMed ID: 36082777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13
    Hu C; You W; Kong D; Huang Y; Lu J; Zhao M; Jin Y; Peng R; Hua D; Kuang DM; Chen Y
    Gastroenterology; 2024 Jun; 166(6):1069-1084. PubMed ID: 38445519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology.
    Vanmeerbeek I; Govaerts J; Laureano RS; Sprooten J; Naulaerts S; Borras DM; Laoui D; Mazzone M; Van Ginderachter JA; Garg AD
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer.
    Ukita M; Hamanishi J; Yoshitomi H; Yamanoi K; Takamatsu S; Ueda A; Suzuki H; Hosoe Y; Furutake Y; Taki M; Abiko K; Yamaguchi K; Nakai H; Baba T; Matsumura N; Yoshizawa A; Ueno H; Mandai M
    JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35552285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of tertiary lymphoid structure formation: cooperation between inflammation and antigenicity.
    Khanal S; Wieland A; Gunderson AJ
    Front Immunol; 2023; 14():1267654. PubMed ID: 37809103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation.
    Domblides C; Rochefort J; Riffard C; Panouillot M; Lescaille G; Teillaud JL; Mateo V; Dieu-Nosjean MC
    Front Immunol; 2021; 12():698604. PubMed ID: 34276690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tertiary lymphoid structures and associated plasma cells play an important role in the biology of triple-negative breast cancers.
    Seow DYB; Yeong JPS; Lim JX; Chia N; Lim JCT; Ong CCH; Tan PH; Iqbal J
    Breast Cancer Res Treat; 2020 Apr; 180(2):369-377. PubMed ID: 32034580
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tertiary lymphoid structure patterns predicted anti-PD1 therapeutic responses in gastric cancer.
    Jiang Q; Tian C; Wu H; Min L; Chen H; Chen L; Liu F; Sun Y
    Chin J Cancer Res; 2022 Aug; 34(4):365-382. PubMed ID: 36199531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value, DNA variation and immunologic features of a tertiary lymphoid structure-related chemokine signature in clear cell renal cell carcinoma.
    Xu W; Ma C; Liu W; Anwaier A; Tian X; Shi G; Qu Y; Wei S; Zhang H; Ye D
    Cancer Immunol Immunother; 2022 Aug; 71(8):1923-1935. PubMed ID: 35043231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.